These 2 Biotech Stocks Are Most Likely to Be Acquired, Says Needham — and They Have Over 60% Upside…
Biotech stocks make for an interesting study. They represent a high-risk sector, characterized by high overheads and a long lead time to develop new products. However, they also have the potential for high rewards when new drugs open up…